Success Metrics

Clinical Success Rate
66.7%

Based on 2 completed trials

Completion Rate
67%(2/3)
Active Trials
1(17%)
Results Posted
0%(0 trials)
Terminated
1(17%)

Phase Distribution

Ph not_applicable
2
33%
Ph phase_4
2
33%
Ph phase_2
1
17%
Ph phase_3
1
17%

Phase Distribution

0

Early Stage

1

Mid Stage

3

Late Stage

Phase Distribution6 total trials
Phase 2Efficacy & side effects
1(16.7%)
Phase 3Large-scale testing
1(16.7%)
Phase 4Post-market surveillance
2(33.3%)
N/ANon-phased studies
2(33.3%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

66.7%

2 of 3 finished

Non-Completion Rate

33.3%

1 ended early

Currently Active

1

trials recruiting

Total Trials

6

all time

Status Distribution
Active(2)
Completed(2)
Terminated(1)
Other(1)

Detailed Status

Completed2
Recruiting1
Not yet recruiting1
Suspended1
Terminated1

Development Timeline

Analytics

Development Status

Total Trials
6
Active
1
Success Rate
66.7%
Most Advanced
Phase 4

Trials by Phase

Phase 21 (16.7%)
Phase 31 (16.7%)
Phase 42 (33.3%)
N/A2 (33.3%)

Trials by Status

recruiting117%
completed233%
not_yet_recruiting117%
suspended117%
terminated117%

Recent Activity

1 active trials
Showing 5 of 6
recruitingnot_applicable

Determinants of Warfarin Metabolism

NCT00162474
not_yet_recruitingnot_applicable

Comparison of the Role of Losartan Alone vs Hydrochlorothiazide Plus Losartan

NCT06491940
terminatedphase_2

Losartan Versus Hydrochlorothiazide in Reversing Remodeling of Small Arteries in Pre-Hypertensive Pre-Diabetic Subjects

NCT00388388
completedphase_3

Telmisartan Compared to Losartan + Hydrochlorothiazide in Patients With Mild-to-moderate Essential Hypertension

NCT02183701
completedphase_4

PROBE Parallel 6-week Treatment Comparing Telmisartan/Hydrochlorothiazide (HCT) (40/12.5 or 80/12.5) With Losartan/HCT (50/12.5) Using Ambulatory Blood Pressure Monitoring (ABPM)

NCT00274638
View all 6 trials

Clinical Trials (6)

Showing 6 of 6 trials
NCT00162474Not Applicable

Determinants of Warfarin Metabolism

Recruiting
NCT06491940Not Applicable

Comparison of the Role of Losartan Alone vs Hydrochlorothiazide Plus Losartan

Not Yet Recruiting
NCT00388388Phase 2

Losartan Versus Hydrochlorothiazide in Reversing Remodeling of Small Arteries in Pre-Hypertensive Pre-Diabetic Subjects

Terminated
NCT02183701Phase 3

Telmisartan Compared to Losartan + Hydrochlorothiazide in Patients With Mild-to-moderate Essential Hypertension

Completed
NCT00274638Phase 4

PROBE Parallel 6-week Treatment Comparing Telmisartan/Hydrochlorothiazide (HCT) (40/12.5 or 80/12.5) With Losartan/HCT (50/12.5) Using Ambulatory Blood Pressure Monitoring (ABPM)

Completed
NCT00369538Phase 4

Specific Blockage of Angiotensine 2 and Podocyturia in Glomerular Nephropathies With Hypertension and Proteinuria

Suspended

All 6 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
6